Scientists developed a new CRISPR technology that targets specific RNA molecules. This breakthrough allows for the selective destruction of diseased human cells. The Cas12a2 system differs from Cas9 by targeting RNA instead of DNA. Researchers successfully eliminated cancer cells and HPV-infected cells in laboratory tests.